statistiche ricercatore

GHIDINI, MICHELE

Distribuzione geografica

Continente	#
NA - Nord America	2.298
AS - Asia	1.554
EU - Europa	951
SA - Sud America	98
AF - Africa	38
Totale	4.939

Salva come PNG Salva come JPEG

Nazione	#
US - Stati Uniti d'America	2.221
SG - Singapore	680
IT - Italia	554
CN - Cina	387
VN - Vietnam	160
FR - Francia	150
HK - Hong Kong	131
BD - Bangladesh	83
BR - Brasile	69
DE - Germania	52
GB - Regno Unito	43
IE - Irlanda	41
CA - Canada	34
SE - Svezia	34
IN - India	31
RU - Federazione Russa	26
MX - Messico	22
NG - Nigeria	20
JP - Giappone	15
FI - Finlandia	13
NL - Olanda	12
IQ - Iraq	11
AR - Argentina	10
TH - Thailandia	9
JO - Giordania	7
TR - Turchia	7
ES - Italia	6
ID - Indonesia	6
PL - Polonia	6
HN - Honduras	5
CO - Colombia	4
KE - Kenya	4
LT - Lituania	4
PE - Perù	4
SA - Arabia Saudita	4
VE - Venezuela	4
ZA - Sudafrica	4
AT - Austria	3
EC - Ecuador	3
JM - Giamaica	3
MY - Malesia	3
NI - Nicaragua	3
AE - Emirati Arabi Uniti	2
CL - Cile	2
CR - Costa Rica	2
DZ - Algeria	2
EG - Egitto	2
GT - Guatemala	2
IL - Israele	2
LB - Libano	2
MA - Marocco	2
NP - Nepal	2
OM - Oman	2
PK - Pakistan	2
RS - Serbia	2
TN - Tunisia	2
TT - Trinidad e Tobago	2
AZ - Azerbaigian	1
BB - Barbados	1
BH - Bahrain	1
BZ - Belize	1
CG - Congo	1
GR - Grecia	1
KR - Corea	1
KW - Kuwait	1
LV - Lettonia	1
MD - Moldavia	1
ML - Mali	1
PH - Filippine	1
PR - Porto Rico	1
PT - Portogallo	1
PY - Paraguay	1
SV - El Salvador	1
SY - Repubblica araba siriana	1
TW - Taiwan	1
UA - Ucraina	1
UY - Uruguay	1
UZ - Uzbekistan	1
Totale	4.939

Salva come PNG Salva come JPEG

Città	#
San Jose	588
Council Bluffs	418
Singapore	401
Milan	318
Ashburn	178
Lauterbourg	138
Hong Kong	128
Beijing	96
Rome	59
Chicago	57
Dallas	56
Los Angeles	54
New York	53
Santa Clara	52
Hanoi	49
Ho Chi Minh City	43
Dublin	42
Princeton	36
The Dalles	33
Boardman	28
Nyköping	27
Orem	25
Abuja	20
Frankfurt am Main	20
London	17
Bar Harbor	15
Naples	14
San Diego	14
Schiffdorf	14
Houston	13
Tampa	13
Atlanta	12
Guangzhou	12
Mexico City	12
Brooklyn	11
Salt Lake City	11
Chennai	10
Denver	10
Montreal	10
Phoenix	10
São Paulo	10
Fairfield	9
Helsinki	9
Bangkok	8
Seattle	8
Tianjin	8
Amman	7
Chandler	7
Da Nang	7
Mumbai	7
Poplar	7
Shanghai	7
Turin	7
Hangzhou	6
Las Vegas	6
Nuremberg	6
San Francisco	6
Stockholm	6
Tokyo	6
Warsaw	6
Baghdad	5
Boston	5
Chengdu	5
Detroit	5
Elk Grove Village	5
Hải Dương	5
Ogden	5
Paris	5
Varese	5
Charleston	4
Genoa	4
Haiphong	4
Jacksonville	4
Kingston	4
Miami	4
Pune	4
Shenzhen	4
Sterling	4
Toronto	4
Trapani	4
Woodbridge	4
Amsterdam	3
Ankara	3
Bologna	3
Buffalo	3
Bến Tre	3
Calgary	3
Cambridge	3
Can Tho	3
Changsha	3
Cleveland	3
Covina	3
Curitiba	3
Fayetteville	3
Lancaster	3
Lima	3
Managua	3
Manchester	3
Medina	3
Nairobi	3
Totale	3.410

Salva come PNG Salva come JPEG

Nome	#
Survival benefit with adjuvant chemotherapy in stage III microsatellite-high/deficient mismatch repair colon cancer: a systematic review and meta-analysis	128
A review of clinical practice guidelines and treatment recommendations for cancer care in the COVID-19 pandemic	114
Clinical outcomes of NSCLC patients experiencing early immune-related adverse events to PD-1/PD-L1 checkpoint inhibitors leading to treatment discontinuation	111
Immune-related Adverse Events of Pembrolizumab in a Large Real-world Cohort of Patients With NSCLC With a PD-L1 Expression ≥ 50% and Their Relationship With Clinical Outcomes	95
Safety of extended interval dosing immune checkpoint inhibitors: a multicenter cohort study	79
Impact of bmi on survival outcomes of immunotherapy in solid tumors: A systematic review	79
Triage process for the assessment of coronavirus disease 2019-positive patients with cancer: The ONCOVID prospective study	78
IDH signalling pathway in cholangiocarcinoma: From biological rationale to therapeutic targeting	76
Type 2 Diabetes Mellitus and Efficacy Outcomes from Immune Checkpoint Blockade in Patients with Cancer	74
Targeting kras in solid tumors: Current challenges and future opportunities of novel kras inhibitors	74
Late immune-related adverse events in long-term responders to PD-1/PD-L1 checkpoint inhibitors: A multicentre study	73
Developing a risk assessment score for patients with cancer during the coronavirus disease 2019 pandemic	72
Surgery or Locoregional Approaches for Hepatic Oligometastatic Pancreatic Cancer: Myth, Hope, or Reality?	71
Practical review for diagnosis and clinical management of perihilar cholangiocarcinoma	71
Association of steroids use with survival in patients treated with immune checkpoint inhibitors: A systematic review and meta-analysis	70
Treatment and outcome for small bowel adenocarcinoma (SBA): a real life experience of two Italian centres	68
Impact of use of gastric-acid suppressants and oral anti-cancer agents on survival outcomes: A systematic review and meta-analysis	67
Metabolic disorders and the risk of cholangiocarcinoma	65
PD-1/PD-L1 checkpoint inhibitors during late stages of life: an ad-hoc analysis from a large multicenter cohort	65
Letter of response to comments on: Developing a risk assessment score for patients with cancer during COVID-19 pandemic: A war on two fronts	65
Strategies for increasing the effectiveness of aromatase inhibitors in locally advanced breast cancer: An evidence-based review on current options	63
Nivolumab plus ipilimumab for the first-line treatment of metastatic NSCLC	63
High familial burden of cancer correlates with improved outcome from immunotherapy in patients with NSCLC independent of somatic DNA damage response gene status	61
Coronavirus infection and immune system: An insight of COVID-19 in cancer patients	60
The appropriateness of invasive ventilation in covid-19 positive cancer patients: Proposal of a new prognostic score	59
A multicenter study of skin toxicity management in patients with left-sided, RAS/BRAF wild-type metastatic colorectal cancer treated with first-line anti-EGFR-based doublet regimen: is there room for improvement?	58
Pharmacotherapeutic advances with anaplastic lymphoma kinase inhibitors for the treatment of non-small cell lung cancer	52
Association of Obesity With Survival Outcomes in Patients With Cancer A Systematic Review and Meta-analysis	51
Clinical Evidence for Microbiome-Based Strategies in Cancer Immunotherapy: A State-of-the-Art Review	42
Adjuvant radiotherapy for Merkel cell carcinoma: A systematic review and meta-analysis	41
FOLFOXIRI Plus Bevacizumab as Conversion Therapy for Patients With Initially Unresectable Metastatic Colorectal Cancer A Systematic Review and Pooled Analysis	39
Molecular profiling of tissue and circulating cancer-related ncRNA in hepatocellular carcinoma	38
Guideline Application in Real world: multi-Institutional Based survey of Adjuvant and first-Line pancreatic Ductal adenocarcinoma treatment in Italy. Primary analysis of the GARIBALDI survey	37
Harrison. Principi di medicina interna.	37
Nanomedicine for the Delivery of RNA in Cancer	36
Trifluridine/tipiracil versus placebo in patients with heavily pretreated metastatic gastric cancer (TAGS): a randomised, double-blind, placebo-controlled, phase 3 trial	35
Better survival of patients with oligo- compared with polymetastatic cancers: A systematic review and meta-analysis of 173 studies	33
How to Best Exploit Immunotherapeutics in Advanced Gastric Cancer: Between Biomarkers and Novel Cell-Based Approaches	33
Platinum dose in neoadjuvant therapy for triple-negative breast cancer: A systematic review and network meta-analysis	32
Molecular profiling of tissue- and circulating cancer related non coding RNAs in hepatocellular carcinoma	31
The Brescia International Multidisciplinary Consensus Guidelines on the Optimal Pathology Assessment and Multidisciplinary Pathways of Non-Pancreatic Neoplasms in and Around the Ampulla of Vater (PERIPAN)	30
Outcomes Following Immune Checkpoint Inhibitor Treatment of Patients With Microsatellite Instability-High Cancers A Systematic Review and Meta-analysis	30
Biliary tract cancer: current challenges and future prospects	29
Renal Function Outcomes in Metastatic Non-Small-Cell Lung Carcinoma Patients Treated with Chemotherapy or Immune Checkpoint Inhibitors: An Unexpected Scenario	28
Body weight loss (BWL) as a prognostic/predictive factor in previously treated patients (pts) with metastatic gastric or gastroesophageal junction cancer (mGC/GEJC): Post-hoc analyses of the phase III tags trial	28
Evaluation of Prognostic Factors for Survival in Transverse Colon Cancer	28
Gemcitabine/Nab-Paclitaxel versus FOLFIRINOX in Locally Advanced Pancreatic Cancer: A European Multicenter Study	27
Adjuvant chemotherapy for resected biliary tract cancers: a systematic review and meta-analysis	26
Changes in clinical presentation, management, and survival outcomes in patients affected by colorectal cancer following COVID-19 pandemic	26
Clinical impact of neutropenia and febrile neutropenia in mCRC pts treated with FOLFOXIRI/bevacizumab (bev): A pooled analysis of TRIBE and TRIBE2 studies	26
Correlation between Olive Oil Intake and Gut Microbiota in Colorectal Cancer Prevention	25
The role of positron emission tomography/computed tomography (Pet/ct) for staging and disease response assessment in localized and locally advanced pancreatic cancer	25
Analysis of symptoms and functional HRQoL scales in TAGS, a phase III trial of trifluridine/tipiracil (FTD/TPI) in metastatic gastric cancer (mGC)	24
Neoadjuvant Treatment for Pancreatic Adenocarcinoma: A False Promise or an Opportunity to Improve Outcome?	24
Use of Antibiotics and Risk of Cancer: A Systematic Review and Meta-Analysis of Observational Studies	24
Incidence of influenza-like illness (ILI) in cancer patients during COVID-19: The ONCOVID prospective observational study	23
Immune-Based Therapies and the Role of Microsatellite Instability in Pancreatic Cancer	23
Treatment options for advanced small bowel adenocarcinoma: a systematic review	23
Real-world guideline application in the management of pancreatic cancer patients: the Italian GARIBALDI study	23
Transformer-based AI approach to unravel long-term, time-dependent prognostic complexity in patients with advanced NSCLC and PD-L1 ≥50%: insights from the pembrolizumab 5-year global registry	23
A new nomogram for estimating survival in patients with brain metastases secondary to colorectal cancer	23
Tumor regression grade and survival after neoadjuvant treatment in gastro-esophageal cancer: A meta-analysis of 17 published studies	23
Advances in the pharmacological management of neutropenia in solid tumors: the advent of biosimilars	23
Syndrome of inappropriate anti-diuretic hormone secretion in cancer patients: results of the first multicenter Italian study	23
Effect of aspirin use on cancer incidence and mortality: An updated systematic review and meta-analysis	22
Vinorelbine in BRAF V600E mutated metastatic colorectal cancer: a prospective multicentre phase II clinical study	22
Expression of exosomal let-7g in biofluids and outcome in colon cancer patient treated with anti-EGFR therapy	22
Prognostic Survival Associated With Left-Sided vs Right-Sided Colon Cancer A Systematic Review and Meta-analysis	22
The impact of prior therapies on outcomes with trifluridine/tipiracil (FTD/TPI) in the phase III TAGS trial	22
Evaluation of Second-Line Anti-VEGF after First-Line Anti-EGFR Based Therapy in RAS Wild-Type Metastatic Colorectal Cancer: The Multicenter "SLAVE" Study	22
Modulation of Biliary Cancer Chemo-Resistance Through MicroRNA-Mediated Rewiring of the Expansion of CD133+Cells	22
The Agnostic Role of Site of Metastasis in Predicting Outcomes in Cancer Patients Treated with Immunotherapy	21
Comparative Efficacy of 21 Treatment Strategies for Resectable Pancreatic Cancer: A Network Meta-Analysis	21
Longitudinal Circulating Levels of miR-23b-3p, miR-126-3p and lncRNA GAS5 in HCC Patients Treated with Sorafenib	21
The sexist behaviour of immune checkpoint inhibitors in cancer therapy?	21
Sequence variation in mature microRNA-608 and benefit from neo-adjuvant treatment in locally advanced rectal cancer patients	21
Total neoadjuvant therapy for initially inoperable pancreatic cancer: A systematic review of phase 2-3 studies	21
MicroRNA deregulation of the serine synthesis pathway controls intrinsic and non-cell autonomous mechanism of resistance to Regorafenib in metastatic colorectal cancer (mCRC)	21
Association of CDX2 Expression With Survival in Early Colorectal Cancer: A Systematic Review and Meta-analysis	20
Multicentre validation of an immune-inflammation-based nomogram to predict survival in western resectable gastroesophageal adenocarcinoma: The NOMOGAST	20
Clinical development of mTor inhibitors for renal cancer	20
Effects of hypertension on cancer survival: A meta-analysis	20
What Medical Oncologist Residents Think about the Italian Speciality Schools: A Survey of the Italian Association of Medical Oncology (AIOM) on Educational, Clinical and Research Activities	20
Efficacy and Safety of Trifluridine/Tipiracil Treatment in Patients With Metastatic Gastric Cancer Who Had Undergone Gastrectomy Subgroup Analyses of a Randomized Clinical Trial	20
MicroRNAs as Mediators of Resistance Mechanisms to Small-Molecule Tyrosine Kinase Inhibitors in Solid Tumours	20
Adjuvant chemotherapy in patients with rectal cancer achieving pathologic complete response after neoadjuvant chemoradiation and surgery	20
Trilaciclib prior to FOLFOXIRI/bevacizumab for patients with untreated metastatic colorectal cancer: phase 3 PRESERVE 1 trial	19
Observational prospective study of Italian guidelines application for patients with pancreatic ductal adenocarcinoma	19
Challenges and perspectives for immunotherapy in oesophageal cancer: A look to the future (Review)	19
Weekly epirubicin as salvage therapy inpatient with gemcitabine-refractory pancreatic cancer	19
New Tools for Precision and Personalized Treatment in Gastrointestinal Cancers	19
Predictors of Lymph Node Metastasis in T1 Colorectal Cancer in Young Patients: Results from a National Cancer Registry	19
Corrigendum to "iNKT cell-neutrophil crosstalk promotes colorectal cancer pathogenesis" [Mucosal Immunol. 16(3) (2023) 326-340	19
Preoperatory FLOT Regimen for Gastroesophageal Cancer and Renal Function: A New Onco-Nephrological Perspective	18
An introduction to the current management of colorectal cancer in the era of personalized oncology	18
Microsatellite Instability and Survival in Stage II Colorectal Cancer: A Systematic Review and Meta-analysis	18
MicroRNAs (miRNAs) and Long Non-Coding RNAs (lncRNAs) as New Tools for Cancer Therapy: First Steps from Bench to Bedside	18
Disease-free survival is not a surrogate endpoint for overall survival in adjuvant trials of pancreatic cancer: a systematic review of randomized trials	18
Major innovations and clinical applications of disodium-levofolinate: a review of available preclinical and clinical data	18
Detection of microRNAs as biomarker for anti-EGFR antibody resistance in colon cancer patients	18
Totale	3.823

Salva come PNG Salva come JPEG

Categoria	#
all - tutte	30.010
article - articoli	0
book - libri	0
conference - conferenze	0
curatela - curatele	0
other - altro	0
patent - brevetti	0
selected - selezionate	0
volume - volumi	0
Totale	30.010

Salva come PNG Salva come JPEG

	Totale	Lug	Ago	Sett	Ott	Nov	Dic	Gen	Feb	Mar	Apr	Mag	Giu
2021/2022	81	0	0	0	0	3	0	35	4	3	2	13	21
2022/2023	115	18	4	8	2	7	29	0	10	12	17	1	7
2023/2024	423	44	77	70	89	112	4	3	3	17	4	0	0
2024/2025	299	5	4	51	4	2	23	4	4	45	33	23	101
2025/2026	4.065	40	62	44	110	411	270	912	306	669	488	423	330
2026/2027	184	184	0	0	0	0	0	0	0	0	0	0	0
Totale													5.167